280 related articles for article (PubMed ID: 24487236)
21. EGFR inhibition by pentacyclic triterpenes exhibit cell cycle and growth arrest in breast cancer cells.
Sathya S; Sudhagar S; Sarathkumar B; Lakshmi BS
Life Sci; 2014 Jan; 95(1):53-62. PubMed ID: 24333132
[TBL] [Abstract][Full Text] [Related]
22. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
24. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
[TBL] [Abstract][Full Text] [Related]
25. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate.
Khan AA; Alanazi AM; Jabeen M; Chauhan A; Abdelhameed AS
Anticancer Res; 2013 Jun; 33(6):2517-24. PubMed ID: 23749903
[TBL] [Abstract][Full Text] [Related]
27. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
[TBL] [Abstract][Full Text] [Related]
28. 3β-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from Plumbago zeylanica inhibits the proliferation and migration of MDA-MB-231 cells.
Sathya S; Sudhagar S; Vidhya Priya M; Bharathi Raja R; Muthusamy VS; Niranjali Devaraj S; Lakshmi BS
Chem Biol Interact; 2010 Dec; 188(3):412-20. PubMed ID: 20670616
[TBL] [Abstract][Full Text] [Related]
29. Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.
Jiang J; Gui F; He Z; Li L; Li Y; Li S; Wu X; Deng Z; Sun X; Huang X; Huang W; Han S; Zhang T; Wang Z; Jiao B; Song S; Wang H; Chen L; Zhou D; Liu Q; Ren R; Zhang J; Deng X
Cancer Res; 2017 Jan; 77(1):175-186. PubMed ID: 27758886
[TBL] [Abstract][Full Text] [Related]
30. Semisynthetic analogues of the marine cembranoid sarcophine as prostate and breast cancer migration inhibitors.
Hassan HM; Sallam AA; Mohammed R; Hifnawy MS; Youssef DT; El Sayed KA
Bioorg Med Chem; 2011 Aug; 19(16):4928-34. PubMed ID: 21775154
[TBL] [Abstract][Full Text] [Related]
31. Discovery of 4-anilino α-carbolines as novel Brk inhibitors.
Mahmoud KA; Krug M; Wersig T; Slynko I; Schächtele C; Totzke F; Sippl W; Hilgeroth A
Bioorg Med Chem Lett; 2014 Apr; 24(8):1948-51. PubMed ID: 24650640
[TBL] [Abstract][Full Text] [Related]
32. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
33. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
Yeh CT; Wu CH; Yen GC
Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
[TBL] [Abstract][Full Text] [Related]
34. A new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer.
Yuan Q; Cai S; Zhang X; Liu Z; Li Z; Luo X; Xiong C; Wang J; Hu J; Ruan J
Cancer Lett; 2012 Nov; 324(2):210-20. PubMed ID: 22652174
[TBL] [Abstract][Full Text] [Related]
35. Design and QSAR study of analogs of alpha-tocopherol with enhanced antiproliferative activity against human breast adenocarcinoma cells.
Nikolic KM
J Mol Graph Model; 2008 Jan; 26(5):868-73. PubMed ID: 17616411
[TBL] [Abstract][Full Text] [Related]
36. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
Nikolic K; Agababa D
J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
[TBL] [Abstract][Full Text] [Related]
37. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
[TBL] [Abstract][Full Text] [Related]
38. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
[TBL] [Abstract][Full Text] [Related]
39. Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).
Uckun FM; Dibirdik I; Qazi S; Vassilev A; Ma H; Mao C; Benyumov A; Emami KH
Bioorg Med Chem; 2007 Jan; 15(2):800-14. PubMed ID: 17098432
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases.
Bijian K; Zhang Z; Xu B; Jie S; Chen B; Wan S; Wu J; Jiang T; Alaoui-Jamali MA
Eur J Med Chem; 2012 Feb; 48():143-52. PubMed ID: 22204902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
